Preliminary takeover offer from Germany's Bayer AG values the company at about $2.4B.

Net profit reached €733M, up from €516M in the same quarter a year ago.

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug.